Company · Private
Calico
Alphabet-backed research company studying the biology of aging and translating that work into therapeutics, including the eIF2B activator fosigotifator for integrated-stress-response-driven disease.
Listing
Private
Ticker
—
Headquarters
South San Francisco, US
Founded
2013
Technology
Fundamental aging biology, integrated stress response
Category
Longevity thesis
Deep mechanistic understanding of aging biology, backed by long-duration capital, can surface intervention points that shorter-horizon programmes miss.
Programmes
- FosigotifatorPhase 1/2
Integrated stress response disorders
Reference information for research context only. It is not a rating, a valuation or investment advice. Published developments appear in the News archive.